Emcure Pharmaceuticals Limited

₹2,280As of Sun 8 Nov 2026, 12:00 UTC
NSE:EMCUREHealthcare
Country India
PE (Fwd) •••
TSR 2Y CAGR 28.01%
Div yield 0.16%
ROE 21.37%
Drug Manufacturers (Specialty & Generic)
Beta (5Y) —
PE TTM 39.56
TSR TTM 73.21%
Mkt cap ₹432.5B
ROIC 17.57%
SE Grade™
Value
Quality
Moat
Consensus
Reference
₹2,868
25.79%
(92.00%)
Sell 1|5|2|5|9
3Q26
4Q26
1Q27
2Q27
Earnings per share₹
51.97
52.04
57.34
61.79
12.60%
10.66%
10.49%
18.44%
Revenue₹B
38.32
38.69
38.66
37.66
7.07%
2.31%
4.02%
1.37%
Peers (US$4.464B)
Cap (US$)
PE
5.568B
42.33x
5.236B
35.06x
4.390B
32.67x
4.448B
27.92x
Capital
TTM
5Y
10Y
Leveragex
1.597
0.082
0.070
EBIT/Intx
2.773
1.426
1.428
Own earn%
(53.73)
(244.66)
(229.46)
Sh yield%
30.93
17.26
16.11
Owners
Insiders/Inst%
14.14
35.60
Short interest%
5.84
SBC / revenue%
2.37
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
25
Op margin range%
3–10
$1 testx
0.0
Incr. ROIC%
79